The Department of Psychiatry is pleased to announce the appointment of Dr. Santokh Singh as Chief of the Department of Psychiatry at the St. Mary’s Hospital Center where he will be replacing Dr. Susanne Lamarre.
Dr. Singh is an Assistant Professor at McGill and has worked as a psychiatrist at St.
On World Cancer Day, Monday, February 4th, 2013, the Cedars Cancer Institute and the Goodman Cancer Research Centre are teaming up to offer a free lecture to dispel some common cancer myths and give the facts about cancer care and research progress being made right here in Montreal.
Leading cancer experts from McGill’s Goodman Cancer Research Centre and the McGill University Health Centre will dispel misconceptions that:
Cancer is my fate
Cancer is a death sentence
and will give you the facts that:
Cancer research is making solid progress
This week, the Department of Psychiatry would like to put the spotlight on Dr. Frank Elgar who was recently awarded the Canada Research Chair Tier 2 Award.
Dr. Elgar is a psychologist with research expertise in social inequalities in health and family influences on child mental health. He received his doctorate in developmental psychology from Dalhousie University and has worked in university and government settings in Canada and the United Kingdom.
The Department of Psychiatry would like to congratulate Dr. Carl Ernst for being the recipient of two recent awards:
the Canada Research Chair Tier 2 Award
the Douglas Hospital Induced-Pluripotent Stem Cell Laboratory for Cognitive Disorders Award
McGill University’s board of governors has adopted a resolution demanding the Quebec government withdraw the cuts it is imposing on universities and restore the funding that was in place, saying the government’s action is “excessive and injurious” to the university.
Message from Normand Rinfret, Director General and CEO
It is with great pleasure that we announce the appointment of Dr. Nadia Szkrumelak to the position of Chief of the Department of Psychiatry.
Dr. Szkrumelak is a graduate of McGill University, and has been a member of the Department of Psychiatry at the MUHC since 1984.
Prescription medications remain one of the most common causes of severe adverse reactions in clinical medicine, accounting for thousands of deaths annually in Canada. The urgent need for rigorous, scientific drug safety research has been clearly understood for decades, but lacked national coordination until the arrival of the Canadian Network for Observational Drug Effect Studies (CNODES), which today released its first report documenting progress towards its goal of creating a fully operational system for rapid assessment of adverse drug effects in Canada.
The Douglas Institute is proud to be one of the ten member organizations of MONTRÉAL WALKS for mental health.
MONTRÉAL WALKS for mental health is an annual event. In 2011, more than 800 people walked together as an effort to help destigmatize mental illness and collect funds to improve mental health services.
On October 14, join the Douglas Institute team, which our Executive Director, Lynne McVey, will also be part of.
Translating Cardiovascular Genome-wide Discoveries to Genomic Medicine
Perspective from the Framingham Heart Study
Dr. Christopher O'Donnell
Associate Director and Scientific Director of Genome Research, Framingham Heart Study
Senior Investigator, National Heart, Lung and Blood Institute
Associate Clinical Professor, Harvard Medical School
caroline [dot] alcaraz [at] mcgill [dot] ca ()